Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Swedish Medical Products Agency allows initiation of phase I trial of ROSgard

Nov. 13, 2018

Mutations in DKGE cause C3 glomerulopathy

Nov. 12, 2018

Purinergic receptor mutations cause congenital neurogenic bladder

Nov. 12, 2018

Visterra initiates first-in-human study with VIS-649 for IgA nephropathy

Nov. 8, 2018

IP6 analogues explored as treatment for kidney stones

Nov. 8, 2018

INS-3001 demonstrates efficacy in rat model of vascular calcifications

Nov. 7, 2018

Goldfinch Bio compound targets TRPC5 for the treatment of focal segmental glomerulosclerosis

Nov. 6, 2018

Acute kidney injury prevented in mice by prophylactic treatment with DNase I inhibitor

Nov. 5, 2018

ZMYM2 -- a new candidate gene for congenital anomalies of the kidney and urinary tract

Nov. 5, 2018

New compound GDT-01 improves diabetic nephropathy in ZSF1 rats

Oct. 31, 2018

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...